Is hypercalcemia an independent prognostic factor in Brazilian patients with multiple myeloma?

被引：0
|
作者：
Hungria, V.
Maiolino, A.
Martinez, G.
Colleoni, G.
Coelho, E.
Rocha, L.
Nunes, R.
Bittencourt, R.
Oliveira, L.
Faria, R. M.
Pasquini, R.
Magalhaes, S.
Souza, C. A.
Pinto Neto, J. V.
Barreto, L.
Andrade, E.
机构：
[1] Santa Casa Sao Paulo, Sao Paulo, Brazil
[2] Univ Fed Rio de Janeiro, Hosp Clementino Fraga Filho, Rio De Janeiro, Brazil
[3] Univ Sao Paulo, Fac Med, Hosp Clin, Sao Paulo, Brazil
[4] Univ Fed Sao Paulo, Hosp Sao Paulo, Sao Paulo, Brazil
[5] HEMOPE, Recife, PE, Brazil
[6] Univ Fed Bahia, Hosp Prof Edgar Santos, Salvador, BA, Brazil
[7] Hosp Brigadeiro, Sao Paulo, Brazil
[8] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil
[9] Hosp Clin Rebeirao Preto, Ribeirao Preto, Brazil
[10] Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil
[11] Univ Fed Parana, Hosp Clin, BR-80060000 Curitiba, Parana, Brazil
[12] HEMOCE, Fortaleza, Ceara, Brazil
[13] Univ Estadual Campinas, Hosp Clin, Campinas, SP, Brazil
[14] Ctr Oncol & Hematol, Brasilia, DF, Brazil
[15] Inst Nacl Canc, Rio De Janeiro, Brazil
[16] Fdn Ctr Control Oncol, Manaus, Amazonas, Brazil
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：203 / 203
页数：1
相关论文
共 50 条
  • [21] MYEOV is a prognostic factor in multiple myeloma
    Moreaux, Jerome
    Hose, Dirk
    Bonnefond, Amelie
    Reme, Thierry
    Robert, Nicolas
    Goldschmidt, Hartmut
    Klein, Bernard
    EXPERIMENTAL HEMATOLOGY, 2010, 38 (12) : 1189 - 1198
  • [22] FERRITIN AS A PROGNOSTIC FACTOR OF MULTIPLE MYELOMA
    Chung, J. S.
    Song, M. K.
    Cho, G. J.
    Choi, Y. J.
    Kwon, B. R.
    Seol, Y. M.
    Joo, Y. D.
    Yang, Y. S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 618 - 618
  • [23] Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients
    Rebmann, Vera
    Schuett, Philipp
    Brandhorst, Dieter
    Opalka, Bertram
    Moritz, Thomas
    Nowrousian, Mohammad Reza
    Grosse-Wilde, Hans
    CLINICAL IMMUNOLOGY, 2007, 123 (01) : 114 - 120
  • [24] Low p27Kip1 expression is an independent adverse prognostic factor in patients with multiple myeloma
    Filipits, M
    Pohl, G
    Stranzl, T
    Kaufmann, H
    Ackermann, J
    Gisslinger, H
    Greinix, H
    Chott, A
    Drach, J
    CLINICAL CANCER RESEARCH, 2003, 9 (02) : 820 - 826
  • [25] A Gene Expression-Based Proliferation Index as Independent Prognostic Factor in Multiple Myeloma
    Hose, D.
    Reme, T.
    Hielscher, T.
    Moreaux, J.
    Meissner, T.
    Seckinger, A.
    Benner, A.
    Hundemer, M.
    Shaughnessy, J. D., Jr.
    Barlogie, B.
    Hillengass, J.
    Bertsch, U.
    Jauch, A.
    Rossi, J. F.
    Moehler, T.
    Klein, B.
    Goldschmid, H.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S98 - S98
  • [26] Multiple myeloma-associated amyloidosis is an independent high-risk prognostic factor
    Vela-Ojeda, J.
    Garcia-Ruiz Esparza, M. A.
    Padilla-Gonzalez, Y.
    Sanchez-Cortes, E.
    Garcia-Chavez, J.
    Montiel-Cervantes, L.
    Reyes-Maldonado, E.
    Majluf-Cruz, A.
    Mayani, H.
    ANNALS OF HEMATOLOGY, 2009, 88 (01) : 59 - 66
  • [27] Multiple myeloma-associated amyloidosis is an independent high-risk prognostic factor
    J. Vela-Ojeda
    M. A. García-Ruiz Esparza
    Y. Padilla-González
    E. Sánchez-Cortes
    J. García-Chávez
    L. Montiel-Cervantes
    E. Reyes-Maldonado
    A. Majluf-Cruz
    H. Mayani
    Annals of Hematology, 2009, 88 : 59 - 66
  • [28] TREATMENT OF HYPERCALCEMIA IN MULTIPLE MYELOMA - REPORT OF 2 PATIENTS
    MERIGAN, TC
    HAYES, RE
    ARCHIVES OF INTERNAL MEDICINE, 1961, 107 (03) : 389 - &
  • [29] Advanced age is not an adverse prognostic factor for patients with multiple myeloma.
    Dimopoulos, M
    Pouli, A
    Zervas, K
    Gika, D
    Repousis, P
    Mitsouli, C
    Grigoraki, V
    Anagnostopoulos, N
    Stamatellou, M
    Symeonidis, A
    Maniatis, A
    BLOOD, 2002, 100 (11) : 600A - 600A
  • [30] Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factor
    Standal, T
    Borset, M
    Lenhoff, S
    Wisloff, F
    Stordal, B
    Sundan, A
    Waage, A
    Seidel, C
    BLOOD, 2002, 100 (12) : 3925 - 3929
12345